Trial · NCT00926289
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From Baseline in Mean Seated Trough Cuff Systolic Blood Pressure (SBP) to Week 7 | Baseline and Week 7 | The SBP value at baseline was subtracted from the SBP value at Week 7. |
| Secondary | Change From Baseline in Mean Seated Trough Cuff SBP to Week 5 | Baseline and Week 5 | The SBP value at baseline was subtracted from the SBP value at Week 5. |
| Secondary | Change From Baseline in Mean Seated Trough Cuff SBP to Week 3 | Baseline and Week 3 | The SBP value at baseline was subtracted from the SBP value at Week 3. |
| Secondary | Change From Baseline in Mean Seated Trough Cuff Diastolic Blood Pressure (DBP) to Week 7 | Baseline and Week 7 | The DBP value at baseline was subtracted from the DBP value at Week 7. |
| Secondary | Number of Patients With SBP Control (SBP < 140 mmHg) at Week 7 | Week 7 timepoint | SBP control is defined as SBP \< 140 mmHg. |
| Secondary | Number of Patients With SBP Control (SBP < 140 mmHg) at Week 5 | Week 5 timepoint | SBP control is defined as SBP \< 140 mmHg |
| Secondary | Number of Patients With SBP Control (SBP < 140 mmHg) at Week 3 | Week 3 timepoint | SBP control is defined as SBP \< 140 mmHg |
| Secondary | Number of Patients With DBP Control (DBP < 90 mmHg) at Week 7 | Week 7 timepoint | DBP control is defined as DBP\<90 mmHg |
| Secondary | Number of Patients With DBP Control (DBP < 90 mmHg) at Week 5 | Week 5 timepoint | DBP control is defined as DBP\<90 mmHg |
| Secondary | Number of Patients With DBP Control (DBP < 90 mmHg) at Week 3 | Week 3 timepoint | DBP control is defined as DBP\<90 mmHg |
| Secondary | Number of Patients With Blood Pressure (BP) Control at Week 7 | Week 7 timepoint | BP control is defined as SBP\<140 mmHg and DBP \< 90 mmHg and is adjusted for baseline SBP |
| Secondary | Number of Patients With BP Control at Week 7 | Week 7 timepoint | BP control is defined as SBP\<140 mmHg and DBP \< 90 mmHg and is adjusted for baseline DBP |
| Secondary | Number of Patients With Systolic Blood Pressure (SBP) Response at Week 7 | Week 7 timepoint | SBP response is defined as SBP\<140 mmHg or a reduction of \>= 15 mmHg |
| Secondary | Number of Participants With DBP Response at Week 7 | Week 7 timepoint | DBP response is defined as DBP\<90 mmHg or a reduction of \>= 10 mmHg |
| Secondary | BP Categories at Week 7 | Week 7 timepoint | BP categories comprise: * BP optimal (SBP \<120 mmHg and DBP \<80 mmHg) * BP normal (SBP \<130 mmHg and DBP \<85 mmHg but not 'optimal') * BP high normal (SBP \<140 mmHg and DBP \<90 mmHg but not 'normal') * Grade 1 hypertension (SBP \<160 mmHg and DBP \<100 mmHg but not 'high normal') * Grade 2 hypertension (SBP \<180 mmHg and DBP \<110 mmHg but not 'Grade 1 hypertension') * Grade 3 hypertension (SBP ≥180 mmHg or DBP ≥110 mmHg) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00926289/registered